MR prediction of liver fibrosis using a liver‐specific contrast agent: Superparamagnetic iron oxide versus Gd‐EOB‐DTPA
Akihiro Nishie(Kyushu University), Hiroshi Honda(Kyushu University), Kengo Yoshimitsu(Kyushu University), Makoto Obara(Philips (Finland)), Daisuke Kakihara(Kyushu University), Yoshiki Asayama(Oita University), Kousei Ishigami(Kyushu University), Akinobu Taketomi(Hokkaido University), Tsuyoshi Tajima(National Center for Global Health and Medicine), Daisuke Okamoto(Kyushu University), Tomohiro Nakayama(Tokyo Women's Medical University), Nobuhiro Fujita(Kyushu University), Yukihisa Takayama(Kyushu University), Ken Shirabe(Gunma University)
Cited by 75
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality
|American Journal of Respiratory and Critical Care Medicine|2019|260
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244